Tudor Investment Corp
MDGL icon

Tudor Investment Corp’s Madrigal Pharmaceuticals MDGL Stock Holding History

Tudor Investment Corp’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.09M Buy
11,630
+6,345
+120% +$3.03M 0.01% 1052
2025
Q4 		$3.08M Buy
5,285
+4,359
+471% +$2.23M 0.01% 1488
2025
Q3 		$425K Buy
+926
New +$345K ﹤0.01% 2780
2025
Q1 		– Sell
-10,327
Closed -$3.39M – 3401
2024
Q4 		$3.19M Buy
+10,327
New +$2.9M 0.01% 941
2024
Q2 		– Sell
-3,258
Closed -$776K – 2596
2024
Q1 		$870K Buy
+3,258
New +$768K 0.01% 1402
2023
Q4 		– Sell
-4,692
Closed -$685K – 2670
2023
Q3 		$685K Buy
4,692
+1,473
+46% +$277K 0.01% 1514
2023
Q2 		$744K Sell
3,219
-9,610
-75% -$2.6M 0.01% 1490
2023
Q1 		$3.11M Buy
12,829
+4,384
+52% +$1.19M 0.05% 573
2022
Q4 		$2.45M Buy
8,445
+617
+8% +$60.3K 0.05% 525
2022
Q3 		$509K Buy
7,828
+11
+0.1% +$764 0.01% 1384
2022
Q2 		$560K Buy
+7,817
New +$575K 0.01% 1219
2022
Q1 		– Sell
-8,536
Closed -$723K – 2414
2021
Q4 		$723K Buy
+8,536
New +$701K 0.01% 1212
2020
Q1 		– Sell
-5,589
Closed -$509K – 1210
2019
Q4 		$509K Buy
+5,589
New +$542K 0.02% 711
2015
Q2 		– Sell
-5,714
Closed -$388K – 1597
2015
Q1 		$388K Buy
+5,714
New +$490K 0.01% 899
2013
Q3 		– Sell
-531
Closed -$93K – 904
2013
Q2 		$93K Buy
+531
New +$138K 0.01% 765

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's MDGL Position: Q1 2026 in Review

Tudor Investment Corp increased its Madrigal Pharmaceuticals (MDGL) stake by 120% in Q1 2026, buying an estimated $3.03M and bringing the position to 11,630 shares worth $6.09M. The position accounts for 0.01% of the portfolio, ranked #1052.

Tudor Investment Corp first reported a position in MDGL in Q2 2013 and has held it in 15 quarters since. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • Tudor Investment Corp held 11,630 shares of Madrigal Pharmaceuticals worth $6.09M as of Q1 2026.
  • Tudor Investment Corp bought 6,345 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $3.03M.
  • Madrigal Pharmaceuticals made up 0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #1052 holding.
  • Tudor Investment Corp first reported a position in Madrigal Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.